BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9882185)

  • 1. Technetium-99m sestamibi uptake in hepatocellular carcinoma.
    Derebek E
    Eur J Nucl Med; 1998 Nov; 25(11):1587-8. PubMed ID: 9882185
    [No Abstract]   [Full Text] [Related]  

  • 2. Technetium-99m methoxyisobutylisonitrile single-photon emission tomography in hepatocellular carcinoma.
    Fukushima K; Kono M; Ishii K; Sakai E; Hirota S; Yuri H
    Eur J Nucl Med; 1997 Nov; 24(11):1426-8. PubMed ID: 9371878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of P-glycoprotein and multidrug resistance associated protein gene expression on Tc-99m MIBI imaging in hepatocellular carcinoma.
    Chang CS; Huang WT; Yang SS; Yeh HZ; Kao CH; Chen GH
    Nucl Med Biol; 2003 Feb; 30(2):111-7. PubMed ID: 12623109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant uptake of Tc-99m PMT and Tc-99m GSA by two hepatocellular carcinoma lesions.
    Tanabe Y; Hashimoto M; Ohuchi Y; Kodama F; Ogawa T
    Ann Nucl Med; 2000 Dec; 14(6):485-8. PubMed ID: 11210102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased 99mTc-sestamibi accumulation in normal liver and drug-resistant tumors after the administration of the glycoprotein inhibitor, XR9576.
    Agrawal M; Abraham J; Balis FM; Edgerly M; Stein WD; Bates S; Fojo T; Chen CC
    Clin Cancer Res; 2003 Feb; 9(2):650-6. PubMed ID: 12576431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma: uptake of 99mTc-IDA in primary tumor and metastasis.
    Lee VW; O'Brien MJ; Devereux DF; Morris PM; Shapiro JH
    AJR Am J Roentgenol; 1984 Jul; 143(1):57-61. PubMed ID: 6328961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iso-intense gallium uptake in hepatocellular carcinoma: potential pitfalls in diagnosis.
    Lee VW; Staffa M
    Nucl Med Commun; 1988 Apr; 9(4):309-15. PubMed ID: 2840616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m MDP uptake in hepatoblastoma.
    Elgazzar AH; Jahan S; Motawei S; Abdel-Dayem HM
    Clin Nucl Med; 1989 Feb; 14(2):143. PubMed ID: 2543533
    [No Abstract]   [Full Text] [Related]  

  • 9. Uptake of hepatobiliary agents by hepatocellular carcinoma.
    Vincent LM; Renner JB
    AJR Am J Roentgenol; 1984 Nov; 143(5):1119-21. PubMed ID: 6091431
    [No Abstract]   [Full Text] [Related]  

  • 10. Uptake of Tc-99m di-isopropyliminodiacetic acid by hepatocellular carcinoma: concise communication.
    Savitch I; Kew MC; Paterson A; Esser JD; Levin J
    J Nucl Med; 1983 Dec; 24(12):1119-22. PubMed ID: 6315902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentavalent Tc-99m dimercaptosuccinic acid imaging of hepatocellular carcinoma.
    Wang SJ; Lin WY; Wey SP; Shen LH; Ting G
    Neoplasma; 1999; 46(4):246-8. PubMed ID: 10613606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
    Aigner RM; Fueger GF; Lax S
    Nuklearmedizin; 1997 Oct; 36(7):256-8. PubMed ID: 9394362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of early uptake of hepatobiliary scan agent in hepatocellular carcinoma].
    Fujikawa M; Okazaki K; Miyao M; Miyazaki M; Onishi S; Ito K; Yoshida S; Nakasato J
    Rinsho Hoshasen; 1986 Jun; 31(6):749-52. PubMed ID: 3020277
    [No Abstract]   [Full Text] [Related]  

  • 14. Uptake of technetium-99m DISIDA by bone metastasis from a hepatoma.
    Pons F; Lomeña F; Calvet X; Bruix J; Catafau A; Ginés A; Herranz R; Setoain J
    Clin Nucl Med; 1988 Apr; 13(4):280-2. PubMed ID: 2836119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy and uptake of technetium-99m sestamibi in breast cancer.
    Derebek E
    Eur J Nucl Med; 1998 Apr; 25(4):448. PubMed ID: 9643975
    [No Abstract]   [Full Text] [Related]  

  • 16. Tc-99m sestamibi uptake and retention in a large hepatoma.
    Sutter CW; Shelton DK
    Clin Nucl Med; 1995 Dec; 20(12):1091. PubMed ID: 8674299
    [No Abstract]   [Full Text] [Related]  

  • 17. False positive uptake of metaiodobenzylguanidine in hepatocellular carcinoma.
    Inoue Y; Akahane M; Kitazawa T; Ijichi H; Obi S; Yoshikawa K; Ohtomo K; Omata M
    Br J Radiol; 2002 Jun; 75(894):548-51. PubMed ID: 12124245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Tc-99m MDP accumulation in soft tissue caused by bicycle riding.
    Kung JW; Yu JQ; Lee B; Alavi A; Zhuang H
    Clin Nucl Med; 2004 Apr; 29(4):279-80. PubMed ID: 15096983
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnostic value of Tc-99m DEIDA in hepatocellular carcinoma.
    Tzen KY; Lee EF; How SW; Hsu JC
    Taiwan Yi Xue Hui Za Zhi; 1982 Jul; 81(7):945-50. PubMed ID: 6292327
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonvisualization of hepatoma with Tc-99m hepatobiliary agent.
    Lamki N; Raval B; Chamberlain M
    J Nucl Med; 1981 Mar; 22(3):293. PubMed ID: 6259304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.